Brett Matthew Hall - Mar 15, 2024 Form 4 Insider Report for Immuneering Corp (IMRX)

Role
CHIEF SCIENTIFIC OFFICER
Signature
/s/ Michael D. Bookman, Attorney-in-Fact for Brett Matthew Hall
Stock symbol
IMRX
Transactions as of
Mar 15, 2024
Transactions value $
$30,082
Form type
4
Date filed
3/21/2024, 09:06 AM
Previous filing
Feb 9, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IMRX Class A Common Stock Award $10.1K +6.21K +1.87% $1.62 339K Mar 15, 2024 Direct F1, F2, F3
transaction IMRX Class A Common Stock Purchase $20K +7K +2.07% $2.86 346K Mar 20, 2024 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reporting person is voluntarily reporting the acquisition of shares of the issuer's Class A Common Stock pursuant to the Immuneering Corporation 2021 Employee Stock Purchase Plan (the "ESPP"), for the ESPP purchase period of September 15, 2023 through March 15, 2024. This transaction is also exempt pursuant to Rule 16b-3(c) promulgated pursuant to the Securities Exchange Act of 1934.
F2 The relevant Offering Period (as defined in the ESPP) ended, and the shares were acquired, on the Purchase Date (as defined in the ESPP) of March 15, 2024.
F3 In accordance with the ESPP, the shares were purchased at a price not less than eighty-five percent (85%) of the Fair Market Value (as defined in the ESPP) of a share of Class A Common Stock on the Purchase Date of March 15, 2024.